[HTML][HTML] Differential effects of opioid receptor antagonism on the anti-dyskinetic and anti-parkinsonian effects of sub-anesthetic ketamine treatment in a preclinical …

CJ Stopera, MJ Bartlett, C Liu, A Esqueda, R Parmar… - …, 2024 - Elsevier
Sub-anesthetic ketamine treatment has been shown to be an effective therapy for treatment-
resistant depression and chronic pain. Our group has previously shown that sub-anesthetic …

[HTML][HTML] Opioid receptor expressing neurons of the central amygdala gate behavioral effects of ketamine in mice

MB Pomrenze, S Vaillancourt, P Llorach, DR Rijsketic… - bioRxiv, 2024 - ncbi.nlm.nih.gov
Ketamine has anesthetic, analgesic, and antidepressant properties which may involve
multiple neuromodulatory systems. In humans, the opioid receptor (OR) antagonist …